HomeIntroductionOverview of
the consortium
Consensus
Statements
Report &
Recommendations
Future
Guidelines
Training
Manual
 Guide Book for Health-Care Providers
Back to Table of Contents

9.0 The Norplant system

9.1 Method

It is a long acting low dose, reversible, progestin-only method of contraception for women. The system contains 6 capsules each measuring 34 mm in length and 2.4 mm in outer diameter containing 36mg crystalline levonorgestrel. It is effective for up to 5 years after insertion.

9.2 Mechanism of action

The capsule releases approximately 85 µg of LNG per 24 hours during the first 6-12 months of use, and 50 µg/day by 9 months and, thereafter, 30 µg/day for the remaining duration of use. There are three probable mechanisms of action :

• suppresses LH surge necessary for ovulation. About 10% women ovulate during first 2 years of use and 50% by 5 years. But in the ovulatory cycles there is high incidence of ovulatory insufficiency

• thickens cervical mucus and decreases the amount of mucus forming a barrier to sperm penetration

• inhibits endometrial maturation and causes its atrophy thus preventing implantation

9.3 Advantages

• rapidly reversible. Ovulatory cycles are restored within the first month after removal in most women

• highly effective

• continuous method without much effort or motivation by the user

• not a coitus-related method

• user effectiveness closely approximates the theoretical effectiveness

• can be inserted 6 weeks post-partum in lactating women

• no estrogenic side-effects

• prevents iron deficiency anaemia

9.4 Disadvantages

• weight gain

• breast tenderness

• disruption of menstrual cycles especially during first year of use

• insertion and removal requires a surgical procedure by a trained personnel

• higher initial cost as compared to OCPs and barrier methods

• implant is visible under the skin and may be unacceptable to users

• offers no protection against STI / HIV

9.5 Contraindications

• breast-feeding women less than 6 weeks post-partum

• current deep vein thrombosis/pulmonary embolism

• history of stroke

• current or past history of ischaemic heart disease

• migraine with focal neurological deficit

• unexplained vaginal bleeding not evaluated

• current and past history of breast cancer

• active hepatitis, liver tumors

• patient on drugs likely to affect metabolism of LNG eg. - phenytoin, phenobarbitone, rifampicin etc.

9.6 Instructions for use

It is important to know when to insert a Norplant.

During menstrual cycle

• any time it is certain that woman is not pregnant. If started within first 7 days of menstrual bleeding no back-up methods is required.

Post-partum

• breast-feeding mothers as early as 6 weeks post-partum

• non breast-feeding mothers immediately or any time she desires within 6 weeks post-partum

After spontaneous or induced abortion

• immediately or within first 7 days after first or second trimester abortion

When stopping other method

• immediately


Back to Top   |   Back to Table of Contents


Introduction | Overview of the Consortium | Consensus Statements
Report & Recommendations | Future Guidelines | Training Manual
 For more information contact ec_india@hotmail.com | Credits